STP 41ST ANNUAL SYMPOSIUM – Toxicologic Pathology of the Hematopoietic SystemScientific Co-Chairs: Michelle C. Cora, DVM, DACVP, NIEHS/NTP, Research Triangle Park, NC; Basel T. Assaf, BVSc, PhD, DACVP, Sanofi, Cambridge, MA; and David Caudell, DVM, PhD, Wake Forest University, Winston-Salem, NCContinuing Education Chair: Sanjeev Gumber, BVSc, MVSc, PhD, DACVP, Boehringer Ingelheim, Stone Mountain, GAContinuing Education Co-Chair: Maria L. Dagli, DVM, MS, PhD, Universidade de São Paulo, São Paulo, BrazilThe hematopoietic system embodies the convergence of anatomic and clinical pathology specialties and promotes a multidisciplinary approach to assessing disease mechanisms. The aim of the 2022 Society of Toxicologic Pathology Annual Symposium is to converge clinical and anatomic pathology aspects of the hematopoietic system and to expose attendees to a broad array of contemporary topics related to toxicologic pathology of the hematopoietic system. The symposium will kick-off on Monday, June 20, with a Keynote presentation by the world-renowned Dr. Cynthia Dunbar, head of the Molecular Hematopoiesis Section of the National Heart, Lung, and Blood Institute at the National Institutes of Health. The Keynote presentation will be followed by the Monday morning session on bone marrow structure, function and cell biology that will include bone marrow fundamentals, as well as emerging topics on bone marrow physiology and microenvironment as it relates to the nervous system and one’s lifestyle choices. The Monday afternoon session will cover methodologies and emerging technologies for the evaluation of the hematopoietic system, including updates on the evaluation of circulating blood cells and presentations regarding intravital microscopy and lineage tracking by hematopoietic stem cell barcoding. The Tuesday morning session will focus on understanding the mechanisms of decreased erythropoiesis and erythroid cell injury and will include presentations regarding anemias caused from gene mutations or the administration of therapeutics. The Wednesday morning session will be devoted to the hemostatic system with presentations discussing pro- and anti-coagulants, platelet biology, hemorrhagic events in treated leukemic patients, hemophilia B, and assessment of prothrombotic states. The Wednesday afternoon session will address off-target effects and idiosyncratic hematologic effects in toxicology studies with an overview of mechanisms, a talk dedicated to off-target effects in neutrophils and several case presentations. The symposium will conclude with a Thursday morning session focused on hematopoietic neoplasms and clonal diseases in the setting of drug development. Talks will include fundamentals on the classification and animal models of hematopoietic neoplasms, the role of long non-coding RNA in hematopoietic malignancies, and cancer risk associated with the drug development of immunomodulators. On Saturday, June 18, in advance of the STP Annual Symposium, the ever-popular NTP Satellite Symposium, entitled Pathology Potpourri, will focus on presentations of challenging pathologic lesions and on Sunday, two different continuing education courses will be offered. Additionally, Monday evening will offer a hematopoietic mystery slide session.We hope you will join us for this exciting program in the beautiful state of Texas!For more information visit – https://www.toxpath.org/AM2022/general-information.asp
Date(s) - 18/06/2022 - 23/06/2022 All Day
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.